Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma

被引:15
|
作者
Li Mingzhu [1 ]
Zhao Lijun [1 ]
Shen Danhua [1 ]
Li Xiaoping [1 ]
Wang Jianliu [1 ]
Wei Lihui [1 ]
机构
[1] Peking Univ, Dept Obstet & Gynecol, Peoples Hosp, Beijing 100044, Peoples R China
基金
中国国家自然科学基金;
关键词
endometrial carcinoma; immunohistochemistry; clinical factors; biomarkers; P53; CANCER; EXPRESSION; RECEPTOR; KI-67; PTEN; ANGIOGENESIS; PROTEIN; BCL-2; KI67;
D O I
10.3760/cma.j.issn.0366-6999.20132774
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Endometrial carcinoma is one of the most common gynecological cancers and the incidence has been increasing. This study was to identify the relationship of estrogen receptor (ER), progestrone receptor (PR), P53 protein, Ki-67 and phosphatase and tensin homolog deleted on chromosome ten (PTEN) with endometrial carcinoma, the assessment of these bionnarkers and their association with clinicopathological parameters was performed. Methods A total of 198 cases of primary endometrial carcinoma were investigated for ER, PR, Ki-67, P53, and PTEN antigens by immunohistochemical methods. The association of these markers with age, menopause status, histological type, FIGO stage, grading, depth of invasion, lymph node involvement and serum tumor marker was examined. Results The percentages of Ki-67- and P53-negative endometrial tumors were significantly higher in ER-positive compared with ER-negative tumors (both P=0.000). The same trend was evident with PR status. The percentage of PTEN-positive tumors was significantly higher in PR-positive compared with PR-negative tumors (P=0.021), but was no difference in tumors with different ER status. There was no clear association between PTEN positivity and clinicopathological parameters except more relevance with endometrioid histotype (P=0.013). There was a statistically significant difference in the distribution of the different combined biological factors examined in disease-free survival. Conclusions ER and PR status were significant predictors with staging, grading and recurrence. P53 and Ki-67 expression were inversely correlated with both ER and PR expression and have more aggressive clinicopathological features. PTEN expression was inversely correlated with PR expression but not with ER expression. The combined type of ER+PR+P53-PTEN+ was in the majority in endometrial cancer and seemed to be related to better clinical outcome. The combination of ER PR P53+PTEN- represented the worst disease-free survival and was strongly associated with
引用
收藏
页码:1459 / 1463
页数:5
相关论文
共 50 条
  • [1] Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma
    Li Mingzhu
    Zhao Lijun
    Shen Danhua
    Li Xiaoping
    Wang Jianliu
    Wei Lihui
    中华医学杂志(英文版), 2014, (08) : 1459 - 1463
  • [2] Prognostic biomarkers in endometrial and ovarian carcinoma
    Xavier Matias-Guiu
    Ben Davidson
    Virchows Archiv, 2014, 464 : 315 - 331
  • [3] Prognostic biomarkers in endometrial and ovarian carcinoma
    Matias-Guiu, Xavier
    Davidson, Ben
    VIRCHOWS ARCHIV, 2014, 464 (03) : 315 - 331
  • [4] PROGNOSTIC VALUE OF PERITONEAL CYTOLOGY IN ENDOMETRIAL CARCINOMA
    GRIMSHAW, RN
    TUPPER, WC
    FRASER, RC
    TOMPKINS, MG
    JEFFREY, JF
    GYNECOLOGIC ONCOLOGY, 1990, 36 (01) : 97 - 100
  • [5] Prognostic biomarkers for cholangiocarcinoma and their clinical implications
    Saengboonmee, Charupong
    Sawanyawisuth, Kanlayanee
    Chamgramol, Yaovalux
    Wongkham, Sopit
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (06) : 579 - 592
  • [6] Prognostic value of circulating and tumor microenvironmental biomarkers in endometrial cancer
    Ozturk, Seda Duman
    Turan, Gupse
    Gezer, Sener
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 266
  • [7] Independent prognostic value of peritoneal immunocytodiagnosis in endometrial carcinoma
    Benevolo, M
    Mariani, L
    Vocaturo, G
    Vasselli, S
    Natali, PG
    Mottolese, M
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (02) : 241 - 247
  • [8] Peritoneal cytology and its prognostic value in endometrial carcinoma
    Ebina, Y
    Hareyama, H
    Sakuragh, N
    Yamamoto, R
    Furuya, M
    Sogame, M
    Fujino, T
    Makinoda, S
    Fujimoto, S
    INTERNATIONAL SURGERY, 1997, 82 (03) : 244 - 248
  • [9] Identifying prognostic biomarkers in endometrial carcinoma based on ceRNA network
    Zhao, Dongli
    Ren, Chune
    Yao, Yan
    Wang, Qinjian
    Li, Fei
    Li, Yang
    Jiang, Aifang
    Wang, Guili
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (03) : 2437 - 2446
  • [10] THE PROGNOSTIC VALUE OF QUANTITATIVE-ANALYSIS IN THE ENDOMETRIAL CARCINOMA
    AALTO, ML
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1988, 29 (02): : 159 - 165